CN104498437B - 一种体外重组的屏障缺陷表皮模型及构建方法 - Google Patents
一种体外重组的屏障缺陷表皮模型及构建方法 Download PDFInfo
- Publication number
- CN104498437B CN104498437B CN201410803937.2A CN201410803937A CN104498437B CN 104498437 B CN104498437 B CN 104498437B CN 201410803937 A CN201410803937 A CN 201410803937A CN 104498437 B CN104498437 B CN 104498437B
- Authority
- CN
- China
- Prior art keywords
- model
- cell
- defect
- nutrient solution
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410803937.2A CN104498437B (zh) | 2014-12-19 | 2014-12-19 | 一种体外重组的屏障缺陷表皮模型及构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410803937.2A CN104498437B (zh) | 2014-12-19 | 2014-12-19 | 一种体外重组的屏障缺陷表皮模型及构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104498437A CN104498437A (zh) | 2015-04-08 |
CN104498437B true CN104498437B (zh) | 2018-03-23 |
Family
ID=52939889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410803937.2A Active CN104498437B (zh) | 2014-12-19 | 2014-12-19 | 一种体外重组的屏障缺陷表皮模型及构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104498437B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101792735A (zh) * | 2010-02-05 | 2010-08-04 | 陕西博鸿生物科技有限公司 | 含色素的人工皮肤检测模型及其制备方法 |
-
2014
- 2014-12-19 CN CN201410803937.2A patent/CN104498437B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101792735A (zh) * | 2010-02-05 | 2010-08-04 | 陕西博鸿生物科技有限公司 | 含色素的人工皮肤检测模型及其制备方法 |
Non-Patent Citations (4)
Title |
---|
A molecular defect in loricin,the major component of the cornified cell envelope, underlies Vohwinkels syndrome;Maestrini E et al;《Nature Genetics》;19960531;第13卷;70-77 * |
Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelop protein;Koch P J et al;《The Journal of Cell Biology》;20061016;第151卷(第2期);389-400 * |
皮肤角质层的相关屏障结构和功能的研究进展;杨扬 等;《中国美容医学》;20120131;第21卷(第1期);158-161 * |
表皮体外重建模型的建立及性状研究;陆洪光;《中国博士学位论文全文数据库》;20070515(第5期);1-75 * |
Also Published As
Publication number | Publication date |
---|---|
CN104498437A (zh) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kapałczyńska et al. | 2D and 3D cell cultures–a comparison of different types of cancer cell cultures | |
Ong et al. | Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies | |
Jana et al. | Crosshatch nanofiber networks of tunable interfiber spacing induce plasticity in cell migration and cytoskeletal response | |
US20100297767A1 (en) | Novel cell culture and methods of producing and collecting cell masses using the same | |
Shin et al. | Extracellular matrix heterogeneity regulates three-dimensional morphologies of breast adenocarcinoma cell invasion | |
Kagiwada et al. | The mechanical properties of a cell, as determined by its actin cytoskeleton, are important for nanoneedle insertion into a living cell | |
Caleffi et al. | Magnetic 3D cell culture: State of the art and current advances | |
Li et al. | Simultaneous 2D and 3D cell culture array for multicellular geometry, drug discovery and tumor microenvironment reconstruction | |
Dou et al. | A microdevice platform for characterizing the effect of mechanical strain magnitudes on the maturation of iPSC-Cardiomyocytes | |
Soubéran et al. | Practical review on preclinical human 3D glioblastoma models: advances and challenges for clinical translation | |
Choe et al. | A simple metastatic brain cancer model using human embryonic stem cell‐derived cerebral organoids | |
Gündel et al. | Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models | |
CN113583939A (zh) | 一种腺相关病毒跨越血脑屏障模型的构建方法 | |
Wang et al. | Near-physiological microenvironment simulation on chip to evaluate drug resistance of different loci in tumour mass | |
US20160123960A1 (en) | Method for preparing three-dimensional, organotypic cell cultures and uses thereof | |
CN204644371U (zh) | 一种集成式多细胞非接触共培养装置 | |
Jing et al. | Establishment and application of a dynamic tumor-vessel microsystem for studying different stages of tumor metastasis and evaluating anti-tumor drugs | |
Tavana et al. | Aqueous biphasic microprinting approach to tissue engineering | |
CN104498437B (zh) | 一种体外重组的屏障缺陷表皮模型及构建方法 | |
CN102488903A (zh) | miR-224在制备治疗非小细胞肺癌药物中的应用 | |
CN103320494A (zh) | 利用Transwell测量多种细胞对包埋有内皮细胞的细胞基质侵袭性的方法 | |
US20210002666A1 (en) | Methods of genetically modifying animal cells | |
Choi et al. | A rapid quantification of invasive phenotype in head and neck squamous cell carcinoma: A novel 3D pillar array system | |
CN105695392A (zh) | 一种可提高肝细胞体外分化表型及功能的培养方法 | |
Pelofy et al. | Transfer of small interfering RNA by electropermeabilization in tumor spheroids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 523808, 1, building 1, 1, Taoyuan biotechnology cooperation center, Taoyuan hi tech Industrial Development Zone, Songshan hi tech Industrial Development Zone, Guangdong, Dongguan, Taiwan, China 08 Applicant after: Guangdong Bo Xi Biotechnology Co., Ltd. Address before: 710065 Shaanxi City, south of the Second Ring Road, Qinglong District Albert urban vision, No. 1 10C Applicant before: SHAANXI BIOCELL BIOTECHNOLOGY CO., LTD. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: In vitro recombinational barrier defect epidermis model and construction method Effective date of registration: 20200426 Granted publication date: 20180323 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: GUANGDONG BIOCELL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980001783 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210528 Granted publication date: 20180323 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: GUANGDONG BIOCELL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980001783 |